Question 1
1 markA company carries out a double-blind trial of a new antibiotic. Half the patients are given the new antibiotic and half are given an existing antibiotic.
During the trial, who knows which patients are given the new antibiotic?
Choose your answer.
- A the patients only
- B the doctors only
- C the patients and the doctors
- D neither patients nor doctors
Model answer
D - neither the patients nor the doctors.
Explanation
In a double-blind trial neither the patients nor the doctors treating and assessing them know who has the new medicine; the groups are coded and only revealed at the end. This stops patients' expectations and doctors' judgements from biasing the results. In a single-blind trial only the patients do not know.
Mark scheme
-
1 mark
D / neither patients nor doctors (1)
The only correct answer is D. A is not correct because in a double-blind trial the patients do not know which treatment they receive; B is not correct because if only the doctors know, the trial is single-blind, not double-blind; C is not correct because if both know, the trial is not blind at all and the results could be biased. Accept the letter or the option. If more than one option is given, do not award the mark.